PSNL logo

Personalis, Inc. Common Stock

PSNL

PSNL: Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions.

more

Show PSNL Financials

All
Government
Consumer Interest
SEC Filings
ESG/Other

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by PSNL's directors and management

Government lobbying spending instances

  • $10,000 Jul 20, 2023 Issue: Budget/Appropriations Veterans
  • $50,000 Apr 20, 2023 Issue: Budget/Appropriations Veterans
  • $50,000 Jan 20, 2023 Issue: Budget/Appropriations Veterans
  • $50,000 Oct 20, 2022 Issue: Budget/Appropriations Veterans
  • $50,000 Jul 20, 2022 Issue: Budget/Appropriations Veterans
  • $50,000 Apr 20, 2022 Issue: Budget/Appropriations Veterans
  • $50,000 Jan 20, 2022 Issue: Budget/Appropriations Veterans
  • $50,000 Oct 20, 2021 Issue: Budget/Appropriations Veterans
U.S. Patents

New patents grants

  • Patent Title: Methods for using mosaicism in nucleic acids sampled distal to their origin Sep. 12, 2023
  • Patent Title: Methods for using mosaicism in nucleic acids sampled distal to their origin May. 16, 2023
  • Patent Title: Methods and systems for genetic analysis May. 16, 2023
  • Patent Title: Methods and systems for genetic analysis May. 09, 2023
  • Patent Title: Methods for analyzing genotypes May. 02, 2023
  • Patent Title: Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples Apr. 25, 2023
  • Patent Title: Methods and systems for genetic analysis Feb. 28, 2023
  • Patent Title: Methods for using mosaicism in nucleic acids sampled distal to their origin Feb. 21, 2023
  • Patent Title: Methods and systems for genomic analysis Sep. 27, 2022
  • Patent Title: Methods and systems for genetic analysis Aug. 09, 2022
  • Patent Title: Methods and systems for genetic analysis Jul. 12, 2022
  • Patent Title: Methods and systems for genetic analysis Jun. 21, 2022
  • Patent Title: Methods and systems for genetic analysis Apr. 12, 2022
  • Patent Title: Methods and systems for genetic analysis Oct. 26, 2021
  • Patent Title: Methods for using mosaicism in nucleic acids sampled distal to their origin Oct. 12, 2021
  • Patent Title: Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples Oct. 13, 2020
  • Patent Title: Personalized genetic testing Oct. 22, 2019
  • Patent Title: Methods and systems for genetic analysis Sep. 17, 2019
  • Patent Title: Methods and systems for genetic analysis Apr. 23, 2019
  • Patent Title: Methods for analyzing genotypes Apr. 09, 2019
  • Patent Title: Methods for using mosaicism in nucleic acids sampled distal to their origin Nov. 13, 2018
  • Patent Title: Methods and systems for genomic analysis Jul. 24, 2018
  • Patent Title: Methods and systems for genetic analysis Aug. 29, 2017
  • Patent Title: Methods and systems for genomic analysis Aug. 08, 2017
  • Patent Title: Methods and systems for genomic analysis Nov. 10, 2015
  • Patent Title: Methods and systems for genetic analysis Sep. 08, 2015
WallStreetBets

Number of mentions of PSNL in WallStreetBets Daily Discussion

PSNL News

Recent insights relating to PSNL

CNBC Recommendations

Recent picks made for PSNL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PSNL

Corporate Flights

Flights by private jets registered to PSNL